JP2018534946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534946A5 JP2018534946A5 JP2018542687A JP2018542687A JP2018534946A5 JP 2018534946 A5 JP2018534946 A5 JP 2018534946A5 JP 2018542687 A JP2018542687 A JP 2018542687A JP 2018542687 A JP2018542687 A JP 2018542687A JP 2018534946 A5 JP2018534946 A5 JP 2018534946A5
- Authority
- JP
- Japan
- Prior art keywords
- fragment
- seq
- nucleic acid
- acid sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012634 fragment Substances 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 7
- 102000040430 polynucleotide Human genes 0.000 claims 7
- 239000002157 polynucleotide Substances 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 150000007523 nucleic acids Chemical group 0.000 claims 6
- 108020005345 3' Untranslated Regions Proteins 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- 108091034057 RNA (poly(A)) Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562246841P | 2015-10-27 | 2015-10-27 | |
| US62/246,841 | 2015-10-27 | ||
| PCT/US2016/059151 WO2017075237A2 (en) | 2015-10-27 | 2016-10-27 | Chimeric post-transcriptional regulatory element |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018534946A JP2018534946A (ja) | 2018-11-29 |
| JP2018534946A5 true JP2018534946A5 (enExample) | 2019-12-05 |
Family
ID=58561919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542687A Pending JP2018534946A (ja) | 2015-10-27 | 2016-10-27 | キメラ転写後調節要素 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10190135B2 (enExample) |
| EP (1) | EP3368672B1 (enExample) |
| JP (1) | JP2018534946A (enExample) |
| CN (1) | CN108291238A (enExample) |
| IL (1) | IL259010A (enExample) |
| WO (1) | WO2017075237A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019028273A1 (en) * | 2017-08-02 | 2019-02-07 | Dna2.0, Inc. Dba Atum | DNA VECTORS AND ELEMENTS FOR SUSTAINED GENE EXPRESSION IN EUKARYOTIC CELLS |
| WO2020118169A1 (en) * | 2018-12-07 | 2020-06-11 | Celltheon Corporation | Matrix attachment regions and uses in promoting gene expression |
| US20230038502A1 (en) | 2019-06-11 | 2023-02-09 | Shire Human Genetic Therapies, Inc. | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| WO2021081280A1 (en) | 2019-10-23 | 2021-04-29 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
| EP4263614A1 (en) | 2020-12-16 | 2023-10-25 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136597A (en) * | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
| US20060019393A1 (en) * | 2003-12-04 | 2006-01-26 | Cannon Paula M | Minimal lentiviral vector system |
| EP2914731B1 (en) * | 2012-11-01 | 2019-09-11 | California Institute of Technology | Reversible gene expression |
| HUE052552T2 (hu) * | 2014-04-09 | 2021-05-28 | Dna Twopointo Inc | Javított nukleinsav-konstrukciók eukarióta génexpresszióhoz |
| WO2015164759A2 (en) * | 2014-04-25 | 2015-10-29 | Bluebird Bio, Inc. | Mnd promoter chimeric antigen receptors |
-
2016
- 2016-10-27 US US15/335,930 patent/US10190135B2/en active Active
- 2016-10-27 WO PCT/US2016/059151 patent/WO2017075237A2/en not_active Ceased
- 2016-10-27 JP JP2018542687A patent/JP2018534946A/ja active Pending
- 2016-10-27 EP EP16860800.8A patent/EP3368672B1/en active Active
- 2016-10-27 CN CN201680068524.1A patent/CN108291238A/zh active Pending
-
2018
- 2018-04-29 IL IL259010A patent/IL259010A/en unknown
- 2018-12-11 US US16/216,636 patent/US20190309322A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012070736A5 (enExample) | ||
| JP2011155981A5 (enExample) | ||
| JP2017212998A5 (enExample) | ||
| JP2010088434A5 (enExample) | ||
| JP2018518163A5 (enExample) | ||
| MX2020005458A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| JP2017048194A5 (enExample) | ||
| JP2013510581A5 (enExample) | ||
| JP2016525888A5 (enExample) | ||
| JP2016034981A5 (enExample) | ||
| BR112019001887A2 (pt) | composições e métodos para o tratamento de doença associada a cep290 | |
| MX372992B (es) | Vector de virus adeno-asociado. | |
| EA201792663A1 (ru) | Способы скрининга бактерий, архей, водорослей и дрожжей с использованием нуклеиновых кислот crispr | |
| EP4659816A3 (en) | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY | |
| JP2013530689A5 (enExample) | ||
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2019530462A5 (enExample) | ||
| JP2008245635A5 (enExample) | ||
| JP2015128433A5 (enExample) | ||
| MX2018015629A (es) | Sistema de vector viral adeno-asociado traslapado doble para la expresion de abc4a. | |
| JP2017501211A5 (enExample) | ||
| JP2012223202A5 (enExample) | ||
| EP3760713A3 (en) | Lipase variants and polynucleotides encoding same | |
| WO2015114112A8 (en) | Protein | |
| JP2013531491A5 (enExample) |